Patents by Inventor HANY MOHAMED ABD EL-MALIK EL-BASSOSSY

HANY MOHAMED ABD EL-MALIK EL-BASSOSSY has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method of treating ischemic heart disease
    Patent number: 9861675
    Abstract: A method of treating ischemic heart disease can include administering a therapeutically effective amount of a composition including date seed nanoparticles to a subject in need thereof. Exemplary suitable dosage forms can include tablet, gel, paste, and suspension. The therapeutically effective amount of the composition including date seed nanoparticles can be about 2.0 mg/kg to about 2.5 mg/kg.
    Type: Grant
    Filed: June 29, 2016
    Date of Patent: January 9, 2018
    Assignee: KING ABDULAZIZ UNIVERSITY
    Inventors: Soad Khalil Al-Jaouni, Seham Al Sayed Abdul-Hady, Hany Mohamed Abd El-Malik El-Bassossy, Numan Abdullah Salah, Magda Mohamed Hagras
  • METHOD OF TREATING ISCHEMIC HEART DISEASE
    Publication number: 20180000883
    Abstract: A method of treating ischemic heart disease can include administering a therapeutically effective amount of a composition including date seed nanoparticles to a subject in need thereof. Exemplary suitable dosage forms can include tablet, gel, paste, and suspension. The therapeutically effective amount of the composition including date seed nanoparticles can be about 2.0 mg/kg to about 2.5 mg/kg.
    Type: Application
    Filed: June 29, 2016
    Publication date: January 4, 2018
    Inventors: SOAD KHALIL AL-JAOUNI, SEHAM AL SAYED ABDUL-HADY, HANY MOHAMED ABD EL-MALIK EL-BASSOSSY, NUMAN ABDULLAH SALAH, MAGDA MOHAMED HAGRAS
  • IN SITU GEL LOADED WITH PHOSPHODIESTERASE TYPE V INHIBITORS NANOEMULSION
    Publication number: 20150099751
    Abstract: The in situ gel loaded with phosphodiesterase Type V (PDE5) inhibitors nanoemulsion was prepared using an innovative approach to reformulate the PDE5 inhibitors in a nanoemulsion, and then loading the nanoemulsion into an in situ gel base. These preparations are administered by intramuscular injection in order to give a depot effect for a period of time that exceeds 15 days. The in situ gel composition gives slow, controlled release of the PDE5 inhibitor. The in situ gel composition is useful for prophylaxis and treatment of some important chronic diseases, such as diabetic complications, benign prostatic hyperplasia, erectile dysfunction, and diseases associated with endothelial dysfunction.
    Type: Application
    Filed: October 7, 2013
    Publication date: April 9, 2015
    Applicant: KING ABDULAZIZ UNIVERSITY
    Inventors: HISHAM AHMED MOHAMMED MOSLI, SALAH ABDELMONEIM GHAREIB ATTEIAH, KHALED MOHAMED HOSNY OMAR, HANY MOHAMED ABD EL-MALIK EL-BASSOSSY, MOHAMED HANY ABDULWAHAB MOSILHY HELAL